Group leader, Principal scientist I, Translational and Systems Pharmacology
Metrum Research Group, Connecticut, United States
Dr. Anna Katharina Wilkins has been an enthusiast of Quantitative Systems Biology and Pharmacology (QSP) modeling since the earliest days of this rapidly evolving field.
As a Principal Scientist and Group Leader in the Translational & Systems Pharmacology Group at Metrum Research Group, she advises project teams deploying QSP modeling to answer critical questions at all stages of the drug development process. Katharina’s primary expertise lies in supporting antibody drug conjugate (ADC) and bispecific antibody assets through their journeys from preclinical development to the clinic. She also engages in internal research efforts to advance the field and is a fervent advocate of open science to make high quality scientific expertise available to all.
Prior to joining Metrum Research Group in 2022, Katharina worked at Applied BioMath for 7 years, formulating mechanistic QSP models designed to support various pharmaceutical collaborators in their preclinical drug development, most often of ADCs, but also of oncolytic virus therapeutics.
Katharina was awarded her Ph.D. in Chemical Engineering (with a minor in Computational Systems Biology) from the Massachusetts Institute of Technology in 2008. She advanced mathematical methods for oscillatory dynamical systems and applied them to the molecular network that generates the circadian rhythms in the human ‘internal clock’, discovering novel structure-function relationships in this complex biological system. Prior to immigrating to the US, she received a Diplome d’Ingenieur de Biotechnologie (a Master’s degree in Biotechnology) from the Ecole Supérieure de Biotechnologie de Strasbourg in 2002.
Disclosure(s): No financial relationships to disclose
Wednesday, November 13, 2024
1:45 PM – 3:15 PM MST
Wednesday, November 13, 2024
1:45 PM – 2:15 PM MST
